P03. FAR13.5_JA_OVER_SAT-36C261-21-AP-5787_Redacted.pdf

This notice is a pre-solicitation for a sole source contract. The Department of Veterans Affairs Network Contracting Office 21 intends to award a one-year contract to Progenics Pharmaceuticals, Inc. to provide Pylarify prostate-specific membrane antigen positive emission tomography prostate cancer imaging agent deliveries to the VA Northern California Health Care System. Pylarify is a radioactive diagnostic agent indicated for PET imaging of PSMA-positive lesions in men with prostate cancer who are candidates for initial or recurrent treatment based on elevated prostate-specific antigen levels. Any business that believes it can provide this product may submit notice by September 21, 2021, though the agency retains sole discretion over competing the acquisition. The North American Industry Classification code is 325412 and Federal Supply Code is 6505.